Abstract:Introduction Ebola virus (EBOV) is an RNA virus of the Filoviridae family that is responsible for outbreaks of hemorrhagic fevers in primates with a lethality rate as high as 90%. EBOV primarily targets host macrophages leading to cell activation and systemic cytokine storm, and fatal infection is associated with an inhibited interferon response, and lymphopenia. The EBOV surface glycoprotein (GP) has been shown to directly induce T cell depletion and can be secreted outside the virion via extracellular vesicles (EVs), though most studies are limited to epithelial cells and underlying mechanisms remain poorly elucidated. Methods To assess the role of GP on EBOV-induced dysregulation of host immunity, we first utilized EBOV virus-like particles (VLPs) expressing VP40 and NP either alone (Bald-VLP) or in conjunction with GP (VLP-GP) to investigate early inflammatory responses in THP-1 macrophages and in a murine model. We then sought to decipher the role of non-classical inflammatory mediators such as EVs over the course of EBOV infection in two EBOV-infected rhesus macaques by isolating and characterizing circulatory EVs throughout disease progression using size exclusion chromatography, nanoparticle tracking-analysis, and LC-MS/MS. Results While all VLPs could induce inflammatory mediators and recruit small peritoneal macrophages, pro-inflammatory cytokine and chemokine gene expression was exacerbated by the presence of GP. Further, quantification of EVs isolated from infected rhesus macaques revealed that the concentration of vesicles peaked in circulation at the terminal stage, at which time EBOV GP could be detected in host-derived exosomes. Moreover, comparative proteomics conducted across EV populations isolated from serum at various time points before and after infection revealed differences in host-derived protein content that were most significantly pronounced at the endpoint of infection, including significant expression of mediators of TLR4 signaling. Discussion These results suggest a dynamic role for EVs in the modification of disease states in the context of EBOV. Overall, our work highlights the importance of viral factors, such as the GP, and host derived EVs in the inflammatory cascade and pathogenesis of EBOV, which can be collectively further exploited for novel antiviral development.

microRNAs and the Ebola Virus

Identification of Ebola Virus Micrornas and Their Putative Pathological Function

A Review of the Interaction between miRNAs and Ebola Virus

Identification and Potential Roles of Human MicroRNAs in Ebola Virus Infection and Disease Pathogenesis

Altered microRNA Transcriptome in Cultured Human Liver Cells upon Infection with Ebola Virus

The Lifecycle of the Ebola Virus in Host Cells.

Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion

RNA Virus-Encoded Micrornas: Biogenesis, Functions and Perspectives on Application

Implications of the virus-encoded miRNA and host miRNA in the pathogenicity of SARS-CoV-2

High-Throughput Sequencing of Putative Novel microRNAs in Rhesus Monkey Peripheral Blood Mononuclear Cells following EV71 and CA16 Infection

Single-Cell Profiling of Ebola Virus Disease In Vivo Reveals Viral and Host Dynamics

Inhibiting the transcription and replication of Ebola viruses by disrupting the nucleoprotein and VP30 protein interaction with small molecules

Machine Learning-Based Analysis of Ebola Virus' Impact on Gene Expression in Nonhuman Primates

Development of a Měnglà virus minigenome and comparison of its polymerase complexes with those of other filoviruses

Development of a Měnglà Virus Minigenome and Comparison of Its Polymerase Complexes Those of Other Filoviruses

Single-cell image-based genetic screens systematically identify regulators of Ebola virus subcellular infection dynamics

Interplay Among Constitutes of Ebola Virus: Nucleoprotein, Polymerase L, Viral Proteins

Extracellular vesicle storm during the course of Ebola virus infection in primates

An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening

The Properties And Functions Of Virus Encoded Microrna, Sirna, And Other Small Noncoding Rnas

In Silico Analyses and Experimental Validation of the MHC Class-I Restricted Epitopes of Ebolavirus GP.